Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05163080 |
| Title | SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (SURVIVE) |
| Acronym | SURVIVE |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | MimiVax, LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California | San Francisco | California | 94143 | United States | Details | |
| Miami Cancer Institute | Miami | Florida | 33176 | United States | Details | |
| Norton Cancer Center | Louisville | Kentucky | 40241 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Atlantic Health | Summit | New Jersey | 07960 | United States | Details | |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14263 | United States | Details | |
| NYU Langone Health | New York | New York | 10016 | United States | Details | |
| Northwell | New York | New York | 10075 | United States | Details | |
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
| Texas Oncology | Austin | Texas | 78705 | United States | Details | |
| Fred Hutchinson Cancer Center (FHCC) | Seattle | Washington | 98109 | United States | Details |